An increasingly utilized front-line therapy, particularly vital when no-reflow causes severe systemic hypotension that contraindicates the use of vasodilatory agents like adenosine or nitroprusside. Administered in 50 to 200 µg intracoronary boluses, epinephrine's beta-2 agonism drives potent microvascular dilation, while its simultaneous beta-1 effects provide essential inotropic support to the stunned myocardium.
Related RCIS terms
Study RCIS terms in context
Cardiac Codex turns definitions like this into a full study system: 179 lessons, 2,198 practice questions with explanations, four blueprint-matched full-length mock exams, live and timed, and Cardiac Coach — an AI tutor grounded in this exact glossary you can ask from any lesson.
Start free Back to the glossary →